These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
899 related articles for article (PubMed ID: 25738576)
1. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis. Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576 [TBL] [Abstract][Full Text] [Related]
2. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis. Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160 [TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways. Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414 [TBL] [Abstract][Full Text] [Related]
4. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway. Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571 [TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy. Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369 [TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation. Mei M; Tang F; Lu M; He X; Wang H; Hou X; Hu J; Xu C; Han R Environ Toxicol Pharmacol; 2015 Nov; 40(3):764-73. PubMed ID: 26433482 [TBL] [Abstract][Full Text] [Related]
7. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway. Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235 [TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway. Lu M; Wang H; Wang J; Zhang J; Yang J; Liang L; Maslov LN Planta Med; 2014 Jan; 80(1):63-9. PubMed ID: 24338553 [TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway. Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645 [TBL] [Abstract][Full Text] [Related]
10. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Alvarez-Guardia D; Palomer X; Coll T; Davidson MM; Chan TO; Feldman AM; Laguna JC; Vázquez-Carrera M Cardiovasc Res; 2010 Aug; 87(3):449-58. PubMed ID: 20211864 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway. Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of TNF-α-mediated NF-κB Activation by Ginsenoside Rg1 Contributes the Attenuation of Cardiac Hypertrophy Induced by Abdominal Aorta Coarctation. Tang F; Lu M; Yu L; Wang Q; Mei M; Xu C; Han R; Hu J; Wang H; Zhang Y J Cardiovasc Pharmacol; 2016 Oct; 68(4):257-264. PubMed ID: 27195652 [TBL] [Abstract][Full Text] [Related]
13. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice. Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892 [TBL] [Abstract][Full Text] [Related]
14. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy. Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028 [TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV Alleviates the Myocardial Damage Induced by Lipopolysaccharide via the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB)/Proliferator-Activated Receptor α (PPARα) Signaling Pathway. Zhang X; Li M; Wang H Med Sci Monit; 2019 Sep; 25():7158-7168. PubMed ID: 31545785 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells. Lu Y; Li S; Wu H; Bian Z; Xu J; Gu C; Chen X; Yang D Int J Mol Med; 2015 Nov; 36(5):1223-32. PubMed ID: 26398547 [TBL] [Abstract][Full Text] [Related]
17. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy. Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924 [TBL] [Abstract][Full Text] [Related]
18. The protective role of peroxisome proliferator-activated receptor γ coactivator-1α in hyperthyroid cardiac hypertrophy. Xu W; Hou D; Jiang X; Lu Z; Guo T; Liu Y; Wang D; Zen K; Yu B; Zhang CY J Cell Physiol; 2012 Sep; 227(9):3243-53. PubMed ID: 22105890 [TBL] [Abstract][Full Text] [Related]
19. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway. Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023 [TBL] [Abstract][Full Text] [Related]
20. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3. Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]